#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Juvenile chronic myelomonocytic leukaemia Pulmonary tuberculosis Cushing's syndrome Anaemia Glomerulonephritis rapidly progressive Dedifferentiated liposarcoma Piriformis syndrome Fibrodysplasia ossificans progressiva Leukoencephalopathy Chronic inflammatory demyelinating polyradiculoneuropathy Ornithine transcarbamoylase deficiency Chemical burn Follicular lymphoma stage II Methylmalonic acidaemia Malignant melanoma More trials…

    Learn about Rare Diseases

    Metachromatic leukodystrophy – Life with Disease Indolent systemic mastocytosis – Diagnostics Ehlers-Danlos syndrome – Trials in Disease Hepatic angiosarcoma – Diagnostics Pemphigoid – Basic Information Mastocytosis Medulloblastoma – Treatment Soft tissue sarcoma – Trials in Disease Retinoblastoma – Life with Disease Primary biliary cholangitis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Human Albumin Solution Lysine Hydrochloride Imiglucerase Maridebart Cafraglutide Temsirolimus Betahistine Dihydrochloride Peboctocogene Camaparvovec Sildenafil Citrate Cefalexin Monohydrate Amb-05X Enpatoran Dc-806 Rivaroxaban Bimatoprost Citric Acid Frexalimab ANTIMETABOLITES Taxanes TIFCEMALIMAB Cagrilintide More therapies…

    Learn about Your Condition

    Psoriatic arthropathy SAPHO syndrome Langerhans cell sarcoma Small for dates baby Oesophageal atresia Mucopolysaccharidosis III Familial mediterranean fever Tympanic membrane perforation Thrombosis Liver transplant rejection Influenza Pancreatitis chronic Intestinal obstruction Dementia Ovarian epithelial cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Fejer Varmegyei Szent Gyoergy Egyetemi Oktato Korhaz…

Fejer Varmegyei Szent Gyoergy Egyetemi Oktato Korhaz

Seregelyesi Ut 3, Szekesfehervar, 8000, Hungary

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Subcutaneous and Intravenous Isatuximab with Pomalidomide and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma recurrent
    Investigated Drugs:
    • Montelukast Sodium
    • Dexamethasone
    • Isatuximab
    Czechia France Germany Greece Hungary Italy +4

  • Study Comparing Pirtobrutinib to Bendamustine and Rituximab for Untreated Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Pirtobrutinib
    • Rituximab
    Austria Bulgaria Czechia France Hungary Italy +4

  • Study on Lowering Cholesterol with Rosuvastatin or Rosuvastatin/Ezetimibe in Patients at High or Very High Risk of Cardiovascular Disease with High Cholesterol

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Ezetimibe
    • Rosuvastatin
    Croatia Germany Hungary Poland Slovenia

  • Study on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Type IIa hyperlipidaemia
    Denmark France Germany Hungary Italy The Netherlands +3

  • Study of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels

    Not recruiting

    3 1
    Investigated Diseases:
    • Familial hypertriglyceridaemia
    • Hyperchylomicronaemia
    Investigated Drugs:
    • Isis 678354 Sodium Salt
    Bulgaria Czechia Denmark Finland France Germany +9

  • Study of Amivantamab and Lazertinib Combination vs. Osimertinib vs. Lazertinib for First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Amivantamab
    • Lazertinib
    • Osimertinib
    Belgium France Germany Hungary Italy The Netherlands +3

  • Study on the Effects of AZD5462 for Patients with Stable Chronic Heart Failure

    Not recruiting

    2 1
    Investigated Diseases:
    • Cardiac failure chronic
    Investigated Drugs:
    • Azd5462
    Bulgaria Czechia Denmark Hungary The Netherlands Poland +1

  • Study on the Effects of MBS2320 for Patients with Idiopathic Pulmonary Fibrosis (IPF)

    Not recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Mbs2320
    France Germany Greece Hungary Italy Spain

  • Study on the Effectiveness and Safety of BAY 3018250 and Low Molecular Weight Heparin for Patients with Proximal Deep Vein Thrombosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Deep vein thrombosis
    • Thrombolysis
    Investigated Drugs:
    • Bay 3018250
    Belgium Bulgaria Czechia France Germany Greece +5

  • Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Aminocaproic Acid
    • Blood And Related Products
    • Etamsylate
    Austria Belgium Bulgaria Czechia Denmark Estonia +13
Previous Page
1 … 5 6 7 8 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!